BEYOND GENOMiX
Proprietary multi-omics platform delivering actionable insights for age-related disease diagnostics and therapeutics
4 employees · est. 2023 · Neuchatel, Switzerland
Gero
AI-driven drug discovery company focused on therapies targeting age-related diseases
140 employees · est. 2018 · Palo Alto, United States
Gero is the older company (2023 vs 2018); Gero is the larger of the two.
10 signals in the last 90 days
Side-by-Side Comparison
| Metric | BEYOND GENOMiX | Gero |
|---|---|---|
| Founded | ||
| Founded | 2023 | 2018 older |
| Headquarters | ||
| Headquarters | Neuchatel, Switzerland | Palo Alto, United States |
| Employees | ||
| Employees | 4 | 140 larger |
| Industry | ||
| Industry | AI, Biotechnology, Health Care | AI, Biotechnology, Insurtech |
| Funding Stage | ||
| Funding Stage | Unknown | Series A |
| Total Funding | ||
| Total Funding | Not tracked yet | $8.20M |
| Funding Rounds | ||
| Funding Rounds | 1 | 3 |
| Services | ||
| Services | Genomics Pipeline Development, Telomere Analysis Technology, AI-powered Senescence Analysis, Multi-omics Data Generation, Machine Learning Insights, End-to-End Aging Hallmarks Analysis | Developing drugs targeting aging, AI models for disease progression, Collaborative drug discovery with pharma companies |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotechnology Researchers, Healthcare Providers, Diagnostics Companies, Longevity Researchers | Pharmaceutical companies, Healthcare researchers, Investors interested in biotechnology, Aging and longevity research institutions |
| Taxonomy | ||
| Taxonomy | Proprietary Multi-Omics, Age-Related Disease Diagnostics, Therapeutics, Swiss Deeptech Start-up, Aging Hallmarks Analysis, Drug Discovery, MedTech, HealthTech, Precision Medicine, Age-Associated Diseases, Diagnostics | AI Drug Discovery, Age-related Diseases, Preclinical Stage, Disease Phenotypes, Real-world Human Data, Genetic Study, Novel Target Discovery, Chronic Diseases, Longevity Research, Marker Identification, Drug Development, MHealth, Digital Health, Biological Age |
| Website | ||
| Website | beyondgenomix.com | gero.ai |
About BEYOND GENOMiX
BEYOND GENOMiX, founded in 2023, is a promising Swiss startup in the AI, Biotechnology, and Health Care industries. Located in Switzerland, this deeptech venture is carving a niche in the burgeoning field of age-related disease diagnostics and therapeutics. The company's compelling slogan, "Proprie...
About Gero
Gero, founded in 2018, is an AI-driven drug discovery company focused on therapies targeting age-related diseases. The company is headquartered in the United States and operates at the intersection of AI, Biotechnology, Insurtech, and Pharmaceutical industries. At its core, Gero aims to eliminate a...
We will tell you when either one moves
BounceWatch watches BEYOND GENOMiX and Gero for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at BEYOND GENOMiX and Gero — by email.
Frequently Asked Questions
Compare BEYOND GENOMiX with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at BEYOND GENOMiX on 11 Mar 2026, and Gero on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.